Building a Multimodal Biomarker Profile: Combining Urine & Plasma ctDNA, RNA & Spatial Biology to Make Bladder-Preservation Decisions with Confidence
8:30 am - Friday 19th March 2027
- Comparing personalized, fixed panel and methylation approaches head-to-head in the same patients to find the sensitivity needed for real clinical decisions
- Combining urine and plasma ctDNA with spatial and transcriptomic data to build a more complete patient profile
- Scaling deeper science into practical diagnostics, including where histopathology AI can reduce testing bottlenecks
